Source:http://linkedlifedata.com/resource/pubmed/id/12778714
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2003-6-3
|
pubmed:abstractText |
Biarylpyrimidines bearing omega-aminoalkyl substituents have been designed as ligands for high-order DNA structures: spectrophotometric, thermal and competition equilibrium dialysis assays showed that changing the functional group for substituent attachment from thioether to amide switches the structural binding preference from triplex to tetraplex DNA; the novel ligands are non-toxic and moderate inhibitors of human telomerase.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1359-7345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1160-1
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Biarylpyrimidines: a new class of ligand for high-order DNA recognition.
|
pubmed:affiliation |
School of Pharmacy, University of Bradford, Bradford, West Yorkshire, UK BD7 1DP.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|